TGFBR2 and neoplasm: Since one component of the M7824 molecule is the TGFßR2, studies were undertaken to determine if the use of M7824, compared to anti-PD-L1, would mitigate or reduce the effect of TGFß on NK-mediated lysis of tumor cells.